Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus. - Wikidata - awgldk - TriplyDB

Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus.

Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus.

http://www.wikidata.org/entity/Q37150868

about

SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4.Immune checkpoint receptors: homeostatic regulators of immunity.

P2860

Q40111809-2CD06146-C47B-47B9-8E35-90B5E63BDCFE Q53685582-31C4D035-D5AD-471B-B556-85951BC0E516

P2860

Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus.

http://www.wikidata.org/entity/Q37150868

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immunoregulatory soluble CTLA- ...... systemic lupus erythematosus.

@en

Immunoregulatory soluble CTLA- ...... systemic lupus erythematosus.

@nl

type

label

Immunoregulatory soluble CTLA- ...... systemic lupus erythematosus.

@en

Immunoregulatory soluble CTLA- ...... systemic lupus erythematosus.

@nl

prefLabel

Immunoregulatory soluble CTLA- ...... systemic lupus erythematosus.

@en

Immunoregulatory soluble CTLA- ...... systemic lupus erythematosus.

@nl

P1433

Q37150868-52551582-2DFF-459E-A0EE-C383DB972CB7

P1476

Q37150868-189C9932-91B6-4436-A48C-0D077BFCD41F

P2093

Q37150868-3D46C4DF-5913-4757-9148-C4D5DBC365DC

Q37150868-42162C3D-BE60-4667-AE51-029FC6B737E5

Q37150868-A1264318-2842-4D41-A4C3-EEB31760989A

Q37150868-B887DEA3-19DC-4A52-981C-850B362E8AFE

Q37150868-CD8EB854-6C5D-42E6-BD1E-E62ECF0A66C3

Q37150868-D0B9437B-3714-41C7-B1F6-15F730189602

Q37150868-F8927501-2AC2-44CC-89F4-23AEEAF99873

P2860

Q37150868-189F081C-7D01-4813-B872-F3EAA02244E9

Q37150868-1E719B71-B015-4342-9E04-FBD16FBB504E

Q37150868-222F3EA3-0778-4B8D-A31C-4030F6871B3C

Q37150868-24BA348B-D68D-4714-A41D-684B9C944993

Q37150868-29217990-7314-4587-AB01-FFA528152CB3

Q37150868-418967C5-BFAC-4C09-A384-CC9B577D70B5

Q37150868-456EAAD0-7A05-419B-8EC8-CC8224E1C22F

Q37150868-4628F8C9-59CA-4B38-B22A-26F6F95A5771

Q37150868-497A069A-F4F3-4A70-949C-18DAC90D69B5

Q37150868-53EB520E-FE86-4753-83A9-BC8D0ACF27E7

P2888

Q37150868-946F9B28-8171-44E1-8064-270C11B9971C

P304

Q37150868-65871DB1-75C1-44A3-B4AF-F81431C8D773

P31

Q37150868-9DDDB5AA-AC09-4FA2-9CD4-FBC1CA8DE62E

P356

Q37150868-2872982D-3BAB-4CF6-B0A7-4679287A11BB

P478

Q37150868-BEB8A0DD-FAB8-4559-A137-7BF0B5E7019B

P577

Q37150868-FD68D171-F293-42B1-8A0A-F326701775C1

P6179

Q37150868-6708DBE0-BB3D-44DC-82B2-C746029B1152

P698

Q37150868-AF5C9237-B178-4F41-A2A1-16ED248DD215

P932

Q37150868-66FE817A-77A0-49F5-9D8F-99448A6D6863

P356

S13075-016-1075-1

P1433

Arthritis Research and Therapy

P1476

Immunoregulatory soluble CTLA- ...... systemic lupus erythematosus.

@en

P2093

Frank J Ward

http://www.w3.org/2001/XMLSchema#string

Hazem Youssef

http://www.w3.org/2001/XMLSchema#string

Lars P Erwig

http://www.w3.org/2001/XMLSchema#string

Lekh N Dahal

http://www.w3.org/2001/XMLSchema#string

Neil Basu

http://www.w3.org/2001/XMLSchema#string

Rahul C Khanolkar

http://www.w3.org/2001/XMLSchema#string

Robert N Barker

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes

A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

A new member of the immunoglobulin superfamily--CTLA-4

A native soluble form of CTLA-4

A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells

Major peptide autoepitopes for nucleosome-specific T cells of human lupus.

Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial.

CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions.

P2888

s13075-016-1075-1

P304

180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13075-016-1075-1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003488665

http://www.w3.org/2001/XMLSchema#string

P698

27487771

http://www.w3.org/2001/XMLSchema#string

P932

4973056

http://www.w3.org/2001/XMLSchema#string